Literature DB >> 17310992

Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.

Z H Wang1, B Shen, H L Yao, Y C Jia, J Ren, Y J Feng, Y Z Wang.   

Abstract

Potassium (K(+)) channels have been implicated in proliferation of some tumor cells. However, whether K(+) channels are important to the pathogenesis of endometrial cancer (EC) remains unknown. In the present study, we report that intermediate-conductance Ca(2+)-activated K(+) (IKCa1) channels play a critical role in the development of EC. The expression of IKCa1 at both mRNA and protein levels in EC tissues was greatly increased than that in atypical hyperplasia and normal tissues. Treatment of EC cells with clotrimazole and TRAM-34, two agents known to inhibit IKCa1 channels, suppressed the proliferation of EC cells and blocked EC cell cycle at G(0)/G(1) phase. Similarly, downregulation of IKCa1 by siRNA against IKCa1 inhibited EC cell proliferation and arrested its cell cycle at G(0)/G(1) phase. A clotrimazole-sensitive K(+) current was induced in EC cells in response to the increased Ca(2+). The current density induced by Ca(2+) was greatly reduced by clotrimazole, TRAM-34, charybdotoxin or downregulation of IKCa1 by the siRNA against IKCa1. Furthermore, TRAM-34 and clotrimazole slowed the formation in nude mice of tumor generated by injection of EC cells. Our results suggest that increased activity of IKCa1 channel is necessary for the development of EC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310992     DOI: 10.1038/sj.onc.1210308

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.

Authors:  Hui Liu; Yufeng Li; Kevin P Raisch
Journal:  Anticancer Drugs       Date:  2010-10       Impact factor: 2.248

2.  Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.

Authors:  Malika Faouzi; Valérie Chopin; Ahmed Ahidouch; Halima Ouadid-Ahidouch
Journal:  J Membr Biol       Date:  2010-02-23       Impact factor: 1.843

Review 3.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

4.  The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.

Authors:  J W Roy; E A Cowley; J Blay; P Linsdell
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

5.  Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.

Authors:  Rong Tao; Chu-Pak Lau; Hung-Fat Tse; Gui-Rong Li
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

6.  Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells.

Authors:  Xiao-Wei Yang; Jin-Wen Liu; Ru-Chao Zhang; Qian Yin; Wen-Zhuang Shen; Ji-Lin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

7.  KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1.

Authors:  Peiyang Lin; Junjing Li; Fugui Ye; Wenfen Fu; Xin Hu; Zhiming Shao; Chuangui Song
Journal:  Am J Cancer Res       Date:  2020-10-01       Impact factor: 6.166

8.  The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.

Authors:  Christian Freise; Martin Ruehl; Daniel Seehofer; Joachim Hoyer; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2012-10-02       Impact factor: 3.850

9.  Calcium-activated K+ channels increase cell proliferation independent of K+ conductance.

Authors:  Joanne E Millership; Daniel C Devor; Kirk L Hamilton; Corina M Balut; Jason I E Bruce; Ian M Fearon
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

10.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.